Recycling cancer-fighting tools: Researchers working to produce vital radioisotopes at a cheaper cost

September 26, 2016, University of Missouri School of Medicine

According to the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes in medicine. Molybdenum-99, the parent isotope of technetium-99m, is the most widely used radioisotope for the diagnosis and treatment of cancer. However, production costs and the limited viability of the isotope can be a challenge for clinicians and healthcare providers. Now, nuclear researchers at the University of Missouri are exploring alternate materials that could be used to help recycle the metals used to produce radioisotopes more efficiently and with less waste. Scientists believe this cheaper method could result in a cost savings for healthcare providers who could pass those savings on to patients.

"Approximately 80 percent of the world's nuclear diagnostic procedures, including bone scans and myocardial stress tests, use technetium-99m to help pinpoint problems in patients," said Silvia Jurisson, professor of chemistry and radiology in the College of Arts and Science and a research investigator with MU Research Reactor (MURR). "While the use of this material has become somewhat routine, the production costs associated with producing this isotope without using is quite costly. Therefore, we're considering other metal target forms that can be irradiated to generate the same diagnostic (molybdenum-99/technetium-99m) and potentially therapeutic (rhenium-186) at a lower cost to suppliers."

Technetium-99m must be produced near the place and time it is used. It is formed when an irradiated metal, such as molybdenum-99, decays. The radioisotope has a half-life of 66 hours; therefore, clinicians have about three days to use the radioisotope before it is no longer viable.

Jurisson, working with Matthew Gott, a recent MU doctoral graduate, decided to build upon previous research to further test three materials: osmium, tungsten and molybdenum. The researchers believed that by chemically combining the three metals with sulfides, they could effectively produce radioisotopes while making the metal easier to reuse. Testing was conducted at MURR as well as Brookhaven National Laboratory where Gott was awarded a fellowship.

"Enriched metal target materials can cost as much as $10,000 for miniscule amounts," Jurisson said. "Therefore, finding ways to recycle and reuse these materials has become an important task. We found that the addition of sulfides to tungsten, osmium and molybdenum—coupled with proper cooling after they had been irradiated—helped us to recover between 88 and 93 percent of the metals while still producing the needed radioisotopes. This means that this very expensive metal can potentially be recycled to cut down on health care costs while still being effective."

Jurisson and her team have continued the research through the summer and are examining other metals to produce other radioisotopes that may have similar properties. The early-stage results of this research are promising. If additional studies are successful within the next several years, then working with physicians at MU will be warranted.

The MU Research Reactor has been a crucial component to research at the university for more than 40 years. Operating 6.5 days a week, 52 weeks a year, scientists from across the campus use the 10-megawatt facility to not only provide crucial radioisotopes for clinical settings globally, but also to carbon date artifacts, improve medical diagnostic tools and prevent illness.

The study, "Accelerator-based production of the 99mTc-186Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2)" was published in the journal Applied Radiation and Isotopes.

Explore further: Nuclear medicine tools could be beneficial in the fight against several human cancers

More information: Matthew D. Gott et al, Accelerator-based production of the 99mTc-186Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2), Applied Radiation and Isotopes (2016). DOI: 10.1016/j.apradiso.2016.05.024

Related Stories

Cancer diagnosis isotopes from Garching

June 27, 2011

The German Federal Ministry of Health has awarded more than one million euros in research and development funding for the efficient production of an important cancer diagnostic agent at the research neutron source FRM II. ...

Canadian Isotope Project enters final stretch

February 15, 2012

A research project exploring the potential for making medical isotopes with X-rays from a particle accelerator instead of a nuclear reactor is about to move to the large scale. The Canadian Isotope Project, led by the Canadian ...

New report examines molybdenum-99 production and use

September 12, 2016

Although the current supply of molybdenum-99 and technetium-99m - isotopes used worldwide in medical diagnostic imaging - is sufficient to meet domestic and global demand, changes to the supply chain before year-end could ...

Recommended for you

Study suggests trees are crucial to the future of our cities

March 25, 2019

The shade of a single tree can provide welcome relief from the hot summer sun. But when that single tree is part of a small forest, it creates a profound cooling effect. According to a study published today in the Proceedings ...

Matter waves and quantum splinters

March 25, 2019

Physicists in the United States, Austria and Brazil have shown that shaking ultracold Bose-Einstein condensates (BECs) can cause them to either divide into uniform segments or shatter into unpredictable splinters, depending ...

Apple pivot led by star-packed video service

March 25, 2019

With Hollywood stars galore, Apple unveiled its streaming video plans Monday along with news and game subscription offerings as part of an effort to shift its focus to digital content and services to break free of its reliance ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.